Interrogating the impact of combination antiretroviral therapies on HIV‐associated neurocognitive disorders

No Neurocognitive Advantage for Immediate Antiretroviral Treatment in adults with greater than 500 CD4+ T Cell Counts

(2018) Edwina J. Wright et al.   AIDS

Antiretroviral Drugs Alter the Content of Extracellular Vesicles from HIV-1-Infected Cells

(2018) Catherine DeMarino et al.   Scientific Reports

Objective and Subjective Improvement of Cognition After Discontinuing Efavirenz in Asymptomatic Patients

(2018) C.S. Hakkers et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Insulin Resistance in HIV-Patients: Causes and Consequences

(2018) Marcelo N. Pedro et al.   Frontiers in Endocrinology

HIV-1 RNA Detected in the CNS after Years of Suppressive Antiretroviral Therapy Can Originate from a Replicating CNS Reservoir or Clonally Expanded Cells

(2018) Sarah B Joseph et al.   CLINICAL INFECTIOUS DISEASES

Persistent metabolic changes in HIV-infected patients during the first year of combination antiretroviral therapy

(2018) N. Chantal Peltenburg et al.   Scientific Reports

Impact of HIV and Atiretroviral Therapy on Neurocognitive Outcomes Among School-Aged Children

(2017) Heena Brahmbhatt et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Differential Effects of Antiretroviral Drugs on Neurons In Vitro: Roles for Oxidative Stress and Integrated Stress Response

(2017) Anna L. Stern et al.   Journal of Neuroimmune Pharmacology

In vitro and Ex vivo Neurotoxic Effects of Efavirenz are Greater than Those of Other Common Antiretrovirals

(2017) Vincent T. Ciavatta et al.   NEUROCHEMICAL RESEARCH

Transdermal rivastigmine for HIV-associated cognitive impairment: A randomized pilot study

(2017) Jose A. Muñoz-Moreno et al.   PLoS One

Prevalence and Correlates of Persistent HIV-1 RNA in Cerebrospinal Fluid During Antiretroviral Therapy

(2016) Albert M. Anderson et al.   JOURNAL OF INFECTIOUS DISEASES

Moderate to severe HIV-associated neurocognitive impairment

(2016) Eric H. Decloedt et al.   MEDICINE

Neuroinflammation in treated HIV-positive individuals

(2016) Jaime H. Vera et al.   NEUROLOGY

Characteristics of Resting-State Functional Connectivity in HIV-Associated Neurocognitive Disorder

(2016) Hea Won Ann et al.   PLoS One

Immune activation in the central nervous system throughout the course of HIV infection

(2016) Serena S. Spudich   Current Opinion in HIV and AIDS

Altered Oligodendrocyte Maturation and Myelin Maintenance: The Role of Antiretrovirals in HIV-Associated Neurocognitive Disorders

(2015) Brigid K. Jensen et al.   JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY

Central nervous system penetration effectiveness of antiretroviral drugs and neuropsychological impairment in the Ontario HIV Treatment Network Cohort Study

(2015) Adriana Carvalhal et al.   JOURNAL OF NEUROVIROLOGY

Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection

(2015)   NEW ENGLAND JOURNAL OF MEDICINE

Circulating HIV DNA Correlates With Neurocognitive Impairment in Older HIV-infected Adults on Suppressive ART

(2015) Michelli Faria de Oliveira et al.   Scientific Reports

Impact of minocycline on cerebrospinal fluid markers of oxidative stress, neuronal injury, and inflammation in HIV-seropositive individuals with cognitive impairment

(2014) Ned Sacktor et al.   JOURNAL OF NEUROVIROLOGY

Antiretroviral drugs induce oxidative stress and neuronal damage in the central nervous system

(2014) Cagla Akay et al.   JOURNAL OF NEUROVIROLOGY

Adjuvant therapies for HIV-associated neurocognitive disorders

(2014) Jennifer L. McGuire et al.   Annals of Clinical and Translational Neurology

Can high central nervous system penetrating antiretroviral regimens protect against the onset of HIV-associated neurocognitive disorders?

(2013) Matteo Vassallo et al.   AIDS

Revised central nervous system neuropenetration-effectiveness score is associated with cognitive disorders in HIV-infected patients with controlled plasma viraemia

(2013) Nicoletta Ciccarelli et al.   ANTIVIRAL THERAPY

Randomized Trial of Central Nervous System–Targeted Antiretrovirals for HIV-Associated Neurocognitive Disorder

(2013) Ronald J. Ellis et al.   CLINICAL INFECTIOUS DISEASES

The NRTIs Lamivudine, Stavudine and Zidovudine Have Reduced HIV-1 Inhibitory Activity in Astrocytes

(2013) Lachlan R. Gray et al.   PLoS One

Cerebrospinal fluid HIV escape associated with progressive neurologic dysfunction in patients on antiretroviral therapy with well controlled plasma viral load

(2012) Michael J. Peluso et al.   AIDS

Antiretroviral monocyte efficacy score linked to cognitive impairment in HIV

(2012) Cecilia M Shikuma et al.   ANTIVIRAL THERAPY

CD4 nadir is a predictor of HIV neurocognitive impairment in the era of combination antiretroviral therapy

(2011) Ronald J. Ellis et al.   AIDS

The definition of HIV-associated neurocognitive disorders: are we overestimating the real prevalence?

(2011) Magnus Gisslén et al.   BMC INFECTIOUS DISEASES

Minocycline treatment for HIV-associated cognitive impairment: Results from a randomized trial

(2011) N. Sacktor et al.   NEUROLOGY

Cognitive dysfunction in HIV patients despite long-standing suppression of viremia

(2010) Samanta Simioni et al.   AIDS

Discordance Between Cerebral Spinal Fluid and Plasma HIV Replication in Patients with Neurological Symptoms Who Are Receiving Suppressive Antiretroviral Therapy

(2010) Ana Canestri et al.   CLINICAL INFECTIOUS DISEASES

HIV‐1 Viral Escape in Cerebrospinal Fluid of Subjects on Suppressive Antiretroviral Treatment

(2010) Arvid Edén et al.   JOURNAL OF INFECTIOUS DISEASES

HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors

(2010) Robert K. Heaton et al.   JOURNAL OF NEUROVIROLOGY

Neurocognitive effects of treatment interruption in stable HIV-positive patients in an observational cohort

(2010) K. R. Robertson et al.   NEUROLOGY

HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study

(2010) R. K. Heaton et al.   NEUROLOGY

HIV, Antiretroviral Therapies, and the Brain

(2010) Kevin J. Liner et al.   Current HIV/AIDS Reports

Impact of combination antiretroviral therapy on cerebrospinal fluid HIV RNA and neurocognitive performance

(2009) Christina M Marra et al.   AIDS

Resting cerebral blood flow: A potential biomarker of the effects of HIV in the brain

(2009) B. M. Ances et al.   NEUROLOGY

Dynamics of cognitive change in impaired HIV-positive patients initiating antiretroviral therapy

(2009) L. A. Cysique et al.   NEUROLOGY

HIV-protease inhibitors induce expression of suppressor of cytokine signaling-1 in insulin-sensitive tissues and promote insulin resistance and type 2 diabetes mellitus

(2008) Michael J. Carper et al.   AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM